Earnings calendar/LCTX
Lineage Cell Therapeutics, Inc. (LCTX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.03
Street estimate
Revenue target
$1.3M
Street estimate
Trailing EPS (avg 4Q)
$-0.05
Beat rate last 4: 25%
Latest EPS YoY
-200.0%
vs 2025-08-12
Latest revenue YoY
-61.3%
How results look so far
Trailing revenue (avg 4Q)
$3.3M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.03 / $-0.03
-6.0%
Revenue actual / est
$1.1M / $1.8M
-42.0%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.03 | Pending | — | $1.3M | Pending | — |
| 8/6/2026 | $-0.03 | $-0.03 | -6.0% | $1.8M | $1.1M | -42.0% |
| 5/12/2026 | $-0.02 | $-0.03 | -50.0% | $3.6M | $1.7M | -52.1% |
| 3/9/2026upcoming | $-0.07 | Pending | — | — | Pending | — |
| 3/5/2026 | $-0.04 | $0.00 | +109.2% | $2.0M | $6.6M | +236.8% |
| 11/6/2025 | $-0.02 | $-0.13 | -550.0% | $2.0M | $3.7M | +87.8% |
| 8/12/2025 | $-0.02 | $-0.01 | +50.0% | $1.5M | $2.8M | +88.6% |
| 5/13/2025 | $-0.02 | $-0.02 | 0.0% | $1.7M | $1.5M | -12.9% |
| 3/10/2025 | $-0.04 | $-0.01 | +75.0% | $1.6M | $2.9M | +78.9% |
| 11/14/2024 | $-0.01 | $-0.02 | -53.8% | $1.6M | $3.8M | +133.1% |
| 8/8/2024 | $-0.05 | $-0.03 | +40.0% | $970,000 | $1.4M | +45.2% |
| 5/9/2024 | $-0.04 | $-0.04 | -4.4% | $1.4M | $1.4M | +6.2% |
| 3/7/2024 | $-0.02 | $-0.03 | -29.9% | $1.3M | $2.1M | +59.4% |
| 11/9/2023 | $-0.04 | $-0.04 | -6.7% | $1.1M | $1.2M | +10.3% |
| 8/10/2023 | $-0.02 | $-0.03 | -32.2% | $2.2M | $3.2M | +46.6% |
| 5/11/2023 | $-0.02 | $-0.03 | -22.0% | $2.0M | $2.4M | +18.7% |
| 3/9/2023 | $-0.03 | $-0.03 | -19.0% | $2.6M | $1.9M | -25.5% |
| 11/10/2022 | $-0.04 | $-0.04 | -14.3% | $3.9M | $3.0M | -23.1% |
| 8/11/2022 | $-0.04 | $-0.04 | -6.7% | $3.7M | $4.6M | +23.6% |
| 5/12/2022 | $-0.03 | $-0.04 | -17.6% | $7.3M | $5.2M | -28.5% |
| 3/10/2022 | $-0.04 | $-0.17 | -325.0% | $840,000 | $1.2M | +39.4% |
Need LCTX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.